These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4402004)

  • 1. The effect of piperonyl butoxide concentration on the formation of cytochrome P-450 difference spectra in hepatic microsomes from mice.
    Philpot RM; Hodgson E
    Mol Pharmacol; 1972 Mar; 8(2):204-14. PubMed ID: 4402004
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of synergists on drug metabolism.
    Hodgson E; Philpot RM; Baker RC; Mailman RB
    Drug Metab Dispos; 1973; 1(1):391-401. PubMed ID: 4149410
    [No Abstract]   [Full Text] [Related]  

  • 3. The production and modification of cytochrome P-450 difference spectra by in vivo administration of methylenedioxyphenyl compounds.
    Philpot RM; Hodgson E
    Chem Biol Interact; 1972 Feb; 4(3):185-94. PubMed ID: 5008936
    [No Abstract]   [Full Text] [Related]  

  • 4. The enzymic formation of methylenedioxyphenyl derivative exhibiting an isocyanide-like spectrum with reduced cytochrome P-450 in hepatic microsomes.
    Franklin MR
    Xenobiotica; 1971 Nov; 1(6):581-91. PubMed ID: 4154538
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical effects of piperonyl butoxide on the kinetics of mouse liver microsomal enzyme activity.
    Friedman MA; Greene EJ; Csillag R; Epstein SS
    Toxicol Appl Pharmacol; 1972 Mar; 21(3):419-27. PubMed ID: 5027973
    [No Abstract]   [Full Text] [Related]  

  • 6. A cytochrome P-450-piperonyl butoxide spectrum similar to that produced by ethyl isocyanide.
    Philpot RM; Hodgson E
    Life Sci II; 1971 May; 10(9):503-12. PubMed ID: 4397161
    [No Abstract]   [Full Text] [Related]  

  • 7. The induction of hepatic cytochrome P-450 in C57 BL/10 and DBA/2 mice by isosafrole and piperonyl butoxide. A comparative study with other inducing agents.
    Fennell TR; Sweatman BC; Bridges JW
    Chem Biol Interact; 1980 Aug; 31(2):189-201. PubMed ID: 7389009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the relationship between the effects of various substances on absorption spectrum of cytochrome P-450 and the reduction of p-nitrobenzoate by mouse liver microsomes.
    Sasame HA; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):123-30. PubMed ID: 4389182
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carrier-bound cytochrome b5 as substrate for the ascorbate: ferricytochrome-b5-oxidoreductase from mammalian liver microsomes (author's transl)].
    Scherer G; Weber H; Weis W
    Hoppe Seylers Z Physiol Chem; 1974 Nov; 355(11):1350-4. PubMed ID: 4461638
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.
    Lettéron P; Fouin-Fortunet H; Tinel M; Danan G; Belghiti J; Pessayre D
    J Pharmacol Exp Ther; 1984 Jun; 229(3):845-50. PubMed ID: 6547179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectral interactions of piperonyl butoxide and isocyanides with purified hepatic cytochrome P-450 from uninduced mice.
    Beumel GA; Levi PE; Hodgson E
    Gen Pharmacol; 1985; 16(3):193-7. PubMed ID: 4018535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
    Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
    Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of metyrapone to cytochrome P-450 and its inhibitory action on microsomal hepatic mixed function oxidation reactions.
    Hildebrandt AG
    Biochem Soc Symp; 1972; 34():79-102. PubMed ID: 4570969
    [No Abstract]   [Full Text] [Related]  

  • 14. Piperonyl butoxide metabolism by cytochrome P-450: factors affecting the formation and disappearance of the metabolite-cytochrome P-450 complex.
    Franklin MR
    Xenobiotica; 1972 Nov; 2(6):517-27. PubMed ID: 4145693
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytochrome P-450 difference spectra: effect of chemical structure on type II spectra in mouse hepatic microsomes.
    Mailman RB; Kulkarni AP; Baker RC; Hodgson E
    Drug Metab Dispos; 1974; 2(3):301-8. PubMed ID: 4152826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inactivation of microsomal proteins by lysosomes (author's transl)].
    Betz H; Gratzl M; Remmer H
    Hoppe Seylers Z Physiol Chem; 1973 May; 354(5):567-75. PubMed ID: 4154275
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme-mediated covalent binding of hydralazine to rat liver microsomes.
    Streeter AJ; Timbrell JA
    Drug Metab Dispos; 1983; 11(3):179-83. PubMed ID: 6135572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation-reduction mechanisms of cytochrome P-450.
    Miyake Y; Mori K; Yamano T
    Biochem Biophys Res Commun; 1971 Aug; 44(3):564-70. PubMed ID: 4399360
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of guinea pig liver and adrenal monooxygenase systems.
    Kupfer D; Orrenius S
    Mol Pharmacol; 1970 May; 6(3):221-30. PubMed ID: 4392663
    [No Abstract]   [Full Text] [Related]  

  • 20. Response of hepatic microsomal mixed-function oxidases to various types of insecticide chemical synergists administered to mice.
    Skrinjarić-Spoljar M; Matthews HB; Engel JL; Casida JE
    Biochem Pharmacol; 1971 Jul; 20(7):1607-18. PubMed ID: 5163091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.